Endothelin-1 in pulmonary hypertension associated with high-altitude exposure

Circulation

Volumn 91, Issue 2, 1995, Pages 359-364

  Goerre, Stefan ^a   Wenk, Markus ^b   Bärtsch, Peter ^c   Lüscher, Thomas F ^b   Niroomand, Feraydoon ^c   Hohenhaus, Elke ^c   Oelz, Oswald ^d   Reinhart, Walter H ^a  

^a KANTONSSPITAL   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d TRIEMLI HOSPITAL   (Switzerland)

Author keywords

arteries; calcium channels; endothelin; hypoxia; pressure

Indexed keywords

CATECHOLAMINE; ENDOTHELIN 1; NIFEDIPINE;

ADULT; ALTITUDE; ALTITUDE DISEASE; ARTERIAL GAS; ARTERIAL PH; ARTICLE; CATECHOLAMINE BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HUMAN EXPERIMENT; HYPOXIA; LUNG ARTERY PRESSURE; LUNG CIRCULATION; MALE; OXYGEN THERAPY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RANDOMIZED CONTROLLED TRIAL;

EID: 0028881583     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.cir.91.2.359     Document Type: Article

References (36)

1. Yanagisawa M, Kurihara H, Kimura S, Mitsui Y, Kobayashi M, Goto K, Katsutoshi G, Yazaki Y, Tomobe Y, Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 1988;332:411-415.
2. Stewart DJ, Levy RD, Cernacek P, Langleben D. Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease? Ann Intern Med. 1991;114:464-469.
3. Giaid A, Yanagisawa M, Langleben D, Michel RP, Levy R, Shennib H, Kimura S, Masaki T, Duguid W, Path FRC, Stewart DJ. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N Engl J Med. 1993;328:1732-1739.
4. Horio T, Kohno M, Yokokawa K, Murakawa K, Yasunari K, Fujiwara H, Kurihara N, Takeda T. Effect of hypoxia on plasma immunoreactive endothelin-1 concentration in anesthetized rats. Metabolism. 1991;40:999-1001.
5. Elton TS, Oparil S, Taylor GR, Hicks PH, Yang RH, Jin H, Chen YF. Normobaric hypoxia stimulates endothelin-1 gene expression in the rat. Am J Physiol. 1992;263:R1260-R1264.
6. Hassoun PM, Thappa V, Landman MJ, Fanburg BL. Endothelin-1: mitogenic activity on pulmonary artery smooth muscle cells and release from hypoxic endothelial cells. Proc Soc Exp Biol Med. 1992;199:165-170.
7. Douglas SA, Vickery-Clark LM, Ohlstein EH. Endothelin-1 does not mediate hypoxic vasoconstriction in canine isolated blood vessels: effect of BQ-123. Br J Pharmacol. 1993;108:418-421.
8. Allen SW, Chatfield BA, Koppenhafer SA, Schaffer MS, Wolfe RR, Abman SH. Circulating immunoreactive endothelin-1 in children with pulmonary hypertension: association with acute hypoxic pulmonary vasoreactivity. Am Rev Respir Dis. 1993;148:519-522.
9. Bärtsch P, Maggiorini M, Ritter M, Noti C, Vock P, Oelz O. Prevention of high-altitude pulmonary edema by nifedipine. N Engl J Med. 1991;325:1284-1289.
10. Hohenhaus E, Niroomand F, Goerre S, Vock P, Oelz O, Bärtsch P. Nifedipine does not prevent acute mountain sickness. Am J Respir Crit Care Med. 1994;150:857-860.
11. Currie PJ, Seward JB, Chan K-L, Fyfe DA, Hagler DJ, Mair DD, Reeder GS, Nishimura RA, Tajik AJ. Continuous wave Doppler determination of right ventricular pressure: a simultaneous Doppler-catheterization study in 127 patients. J Am Coll Cardiol. 1985;6:750-756.
12. Sørensen S. Radioimmunoassay of endothelin in human plasma. Scand J Clin Lab Invest. 1991;51:615-623.
13. Horgan MJ, Pinheiro JMP, Malik AB. Mechanism of endothelin-1-induced pulmonary vasoconstriction. Cire Res. 1991;69:157-164.
14. Lippton HL, Hauth TA, Summer WR, Hyman AL. Endothelin produces pulmonary vasoconstriction and systemic vasodilation. J Appl Physiol. 1989;66:1008-1012.
15. Kourembanas S, Marsden PA, McQuillan LP, Faller DV. Hypoxia induces endothelin gene expression and secretion in cultured human endothelium. J Clin Invest. 1991;88:1054-1057.
16. Chang H, Wu GJ, Wang SM, Hung CR. Effect of pH on endothelin-1 secretion of aortic strips. J Formos Med Assoc. 1993;92:207-212.
17. Hashiguchi K, Takagi K, Nakabayashi M, Takeda Y, Sakamoto S, Naruse M, Naruse K, Demura H. Relationship between fetal hypoxia and endothelin-1 in fetal circulation. J Cardiovasc Pharmacol. 1991;17(suppl 7):S509-S510.
18. Hynynen M, Ilmarinen R, Saijonmaa O, Tikkanen I, Fyhrquist F. Plasma endothelin-1 concentration during cold exposure. Lancet. 1991;337:1104. Letter.
19. Morita T, Kurihara H, Maemura K, Yoshizumi M, Yazaki Y. Disruption of cytoskeletal structures mediates shear stress-induced endothelin-1 gene expression in cultured porcine aortic endothelial cells. J Clin Invest. 1993;92:1706-1712.
20. Carosi JA, McIntire LV. Effects of cyclical strain on the production of vasoactive materials by cultured human and bovine endothelial cells. Eur Respir Rev. 1993;3:598-608.
21. Malek A, Izumo S. Physiological fluid stress causes downregulation of endothelin-1 mRNA in bovine aortic endothelium. Am J Physiol. 1992;263:C389-C396.
22. Malek AM, Greene AL, Izumo S. Regulation of endothelin-1 gene by fluid shear stress is transcriptionally mediated and independent of protein kinase C and cAMP. Proc Natl Acad Sci U S A. 1993;90:5999-6003.
23. Bärtsch P, Maggiorini M, Schobersberger W, Shaw S, Rascher W, Girard J, Weidmann P, Oelz O. Enhanced exercise-induced rise of aldosterone and vasopressin preceding mountain sickness. J Appl Physiol. 1991;71:136-143.
24. Bärtsch P, Shaw S, Franciolli M, Gnädinger MP, Weidmann P. Atrial natriuretic peptide in acute mountain sickness. J Appl Physiol. 1988;65:1929-1937.
25. Veglio F, Bertello P, Pinna G, Mulatero PP, Rossi A, Gurioli L, Panarelli M, Chiandussi L. Plasma endothelin in essential hypertension and diabetes mellitus. J Hum Hypertens. 1993;7:321-326.
26. Knothe C, Boldt J, Zickmann B, Ballesteros M, Dapper F, Hempelmann G. Endothelin plasma levels in old and young patients during open heart surgery: correlations to cardiopulmonary and endocrinology parameters. J Cardiovasc Pharmacol. 1992;20:664-670.
27. Ohnishi A, Minegishi A, Ishizaki T. Effect of beta-adrenoceptor blockade on exercise-induced plasma catecholamine concentration-heart rate response relationship. J Cardiovasc Pharmacol. 1987;10:667-674.
28. Cerasola G, Cottone S, D'Ignoto G, Grasso I, Contorno A, Carone MB, Fulantelli MA. Role of epinephrine in the development of essential hypertension. J Clin Hypertens. 1987;3:670-680.
29. McMurray JJ, Ray SG, Abdullah I, Dargie HJ, Morton JJ. Plasma endothelin in chronic heart failure. Circulation. 1992;85:1374-1379.
30. Ferri C, Latorraca A, Catapano G, Greco F, Mazzoni A, Clerico A, Pedrinelli R. Increased plasma endothelin-1 immunoreactive levels in vasculitis: a clue to the use of endothelin-1 as a marker of vascular damage? J Hypertens. 1993;11(suppl 5):S142-S143.
31. Yamane K, Miyauchi T, Suzuki N, Yuhara T, Akama T, Suzuki H, Kashiwagi H. Significance of plasma endothelin-1 levels in patients with systemic sclerosis. J Rheumatol. 1992;19:1566-1571.
32. Resink TJ, Scott-Burden T, Bühler FR. Endothelin stimulates phospholipase C in cultured vascular smooth muscle cells. Biochem Biophys Res Commun. 1988;157:1360-1368.
33. Aenggard E, Galton S, Rae G, Thomas R, McLoughlin L, de Nucci G, Vane JR. The fate of radioiodinated endothelin-1 and endothelin-3 in the rat. J Cardiovasc Pharmacol. 1989;13(suppl 5):46-49.
34. Lüscher TF. Do we need endothelin antagonists? Cardiovasc Res. 1993;27:2089-2093.
35. Spinella MJ, Malik AB, Everitt J, Andersen TT. Design and synthesis of a specific endothelin-1 antagonist: effects on pulmonary vasoconstriction. Proc Natl Acad Sci USA. 1991;88:7443-7446.
36. Bonvallet ST, Oka M, Yano M, Zamora MR, McMurtry IF, Stelzner TJ. BQ 123, an ET-A receptor antagonist, attenuates endothelin-1-induced vasoconstriction in rat pulmonary circulation. J Cardiovasc Pharmacol. 1993;22:39-43.